This study introduces an innovative sono‐controllable Janus hydrogel platform, GA@CaMP, which integrates precise US‐mediated ROS release control, ZBP1 gene regulation, and the improvement of the hypoxic microenvironment, to address both tumor treatment and bone regeneration in breast cancer bone metastasis. This evidence concerns the gene ZBP1 and breast carcinoma.